학술논문
Prognostic value of platelet to lymphocyte ratio in predicting survival of patients with metastatic castration‐resistant prostate cancer receiving abiraterone acetate: An evidence‐based case report and review of literature.
Document Type
Article
Author
Source
Subject
*CASTRATION-resistant prostate cancer
*ABIRATERONE acetate
*LYMPHOCYTES
*LITERATURE reviews
*PROSTATE cancer patients
*
*
*
*
Language
ISSN
2050-0904
Abstract
Platelet to lymphocyte ratio (PLR) is a candidate prognostic marker for metastatic castration‐resistant prostate cancer patients receiving abiraterone acetate and evidence demonstrates that a high PLR is associated with poor survival. More studies are required to verify current findings and establish a definite cutoff point. [ABSTRACT FROM AUTHOR]